- Investigator
- Arshag Mooradian
- Status
- Accepting Candidates
- Ages
- 75 Years - 100 Years
- Sexes
- All
Treats Adults
Arshag Mooradian, MD
Endocrinologist
Research at a glance
Top areas of exploration
- Aging , 71 publications
- RNA, Messenger , 45 publications
- Apolipoprotein A-I , 41 publications
- Diabetes Mellitus , 39 publications
Research activity
Active clinical trials
My publications
Filter publications
329 publications
2004
Cyclooxygenase inhibition is associated with downregulation of apolipoprotein AI promoter activity in cultured hepatoma cell line HepG2.
Metabolism: clinical and experimental
2004
Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity.
The Journal of clinical endocrinology and metabolism
2004
Towards single-tablet therapy for type 2 diabetes mellitus. Rationale and recent developments.
Treatments in endocrinology
2004
Nutrition principles and recommendations in diabetes.
Diabetes care
2003
Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta.
Biochimica et biophysica acta